Molecular Markers Guiding Thyroid Cancer Management

Abstract excerpt

The incidence of thyroid cancer is rapidly increasing, mostly due to the overdiagnosis and overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical models, high throughput molecular technologies, and gene expression microarrays have provided a deeper understanding of molecular characteristics in cancer. Hence, molecular markers have become a potent tool also in TC management...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Thyroid Cancer Diagnosis and Treatment
• Share to Bioinformatics and Genomic Networks
• Share to Cancer-related Molecular Pathways